scholarly journals Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy

Author(s):  
Ali Salimi Jeda ◽  
Soad Ghabeshi ◽  
Vice-Chancellor for Health Zeinab Gol Mohammad pour ◽  
Ehsan Ollah Jazaeri ◽  
Mehrdad Araiinejad ◽  
...  
Author(s):  
Menghan Gao ◽  
Hong Deng ◽  
Weiqi Zhang

: Hyaluronan (HA) is a natural linear polysaccharide that has excellent hydrophilicity, biocompatibility, biodegradability, and low immunogenicity, making it one of the most attractive biopolymers used for biomedical researches and applications. Due to the multiple functional sites on HA and its intrinsic affinity for CD44, a receptor highly expressed on various cancer cells, HA has been widely engineered to construct different drug-loading nanoparticles (NPs) for CD44- targeted anti-tumor therapy. When a cocktail of drugs is co-loaded in HA NP, a multifunctional nano-carriers could be obtained, which features as a highly effective and self-targeting strategy to combat the cancers with CD44 overexpression. The HA-based multidrug nano-carriers can be a combination of different drugs, various therapeutic modalities, or the integration of therapy and diagnostics (theranostics). Up to now, there are many types of HA-based multidrug nano-carriers constructed by different formulation strategies including drug co-conjugates, micelles, nano-gels and hybrid NP of HA and so on. This multidrug nano-carrier takes the full advantages of HA as NP matrix, drug carriers and targeting ligand, representing a simplified and biocompatible platform to realize the targeted and synergistic combination therapy against the cancers. In this review, recent progresses about HA-based multidrug nano-carriers for combination cancer therapy are summarized and its potential challenges for translational applications have been discussed.


Cells ◽  
2019 ◽  
Vol 9 (1) ◽  
pp. 29 ◽  
Author(s):  
Hyun Ah Seo ◽  
Sokviseth Moeng ◽  
Seokmin Sim ◽  
Hyo Jeong Kuh ◽  
Soo Young Choi ◽  
...  

The susceptibility of cancer cells to different types of treatments can be restricted by intrinsic and acquired therapeutic resistance, leading to the failure of cancer regression and remission. To overcome this problem, a combination therapy has been proposed as a fundamental strategy to improve therapeutic responses; however, resistance is still unavoidable. MicroRNA (miRNAs) are associated with cancer therapeutic resistance. The modulation of dysregulated miRNA levels through miRNA-based therapy comprising a replacement or inhibition approach has been proposed to sensitize cancer cells to other anti-cancer therapies. The combination of miRNA-based therapy with other anti-cancer therapies (miRNA-based combinatorial cancer therapy) is attractive, due to the ability of miRNAs to target multiple genes associated with the signaling pathways controlling therapeutic resistance. In this article, we present an overview of recent findings on the role of therapeutic resistance-related miRNAs in different types of cancer. We review the feasibility of utilizing dysregulated miRNAs in cancer cells and extracellular vesicles as potential candidates for miRNA-based combinatorial cancer therapy. We also discuss innate properties of miRNAs that need to be considered for more effective combinatorial cancer therapy.


Author(s):  
Lokanatha Oruganti ◽  
Balaji Meriga

Background: Scientific research continues to develop more efficacious drugs to treat and cure cancer, the dreadful disease threatening the human race. Chemotherapy is an essential means in cancer therapy, however, plant drugs having pharmacological safety, can be used alone or as additions to current chemotherapeutic agents to enhance therapeutic efficacy and minimize chemotherapy-induced adverse effects. Objective: A combination therapy where the synergistic effect on multiple targets is possible has gained significance, because since a one-drug one-target approach fails to yield the desired therapeutic effect. Therefore, a detailed description of important plant polyphenolic compounds with anticancer activity and their role in potentiating chemotherapeutic efficiency of existing anticancer drugs is provided in this review. Systematically screening combinations of active pharmaceutical ingredients for potential synergy with plant compounds may be especially valuable in cancer therapy. Methodology: We extensively have gone through reviews and research articles available in the literature. We made use of databases such as Google Scholar, Research Gate, PubMed, Science Direct, etc. The following keywords were used in our literature search: “Chemotherapy, drug development, cancer drugs, plant-derived polyphenolics, synergistic studies, combination therapy, diagnosis and genetics.” Conclusion: Systematic research studies on screening combinations of plant phytochemicals with potential chemotherapeutic pharmaceuticals throws light on their synergistic effects, mechanisms of actions paving the way to develop more efficient anticancer therapeutics to treat and cure the cancer menace, to nullify chemotherapy-induced adverse effects and our review substantially contributes in this direction.


Theranostics ◽  
2020 ◽  
Vol 10 (11) ◽  
pp. 4885-4899
Author(s):  
Jiqian Zhang ◽  
Shasha Zhu ◽  
Qilian Tan ◽  
Dan Cheng ◽  
Qingqing Dai ◽  
...  

2017 ◽  
Vol 5 (10) ◽  
pp. 1873-1895 ◽  
Author(s):  
Linji Gong ◽  
Liang Yan ◽  
Ruyi Zhou ◽  
Jiani Xie ◽  
Wei Wu ◽  
...  

In this review, we mainly summarize the latest advances in the utilization of 2D TMDCs for PTT combination cancer therapy and imaging-guided cancer combination therapy, as well as their toxicity bothin vitroandin vivo.


Nanoscale ◽  
2015 ◽  
Vol 7 (21) ◽  
pp. 9433-9437 ◽  
Author(s):  
Jaejung Song ◽  
Kyuhyun Im ◽  
Sekyu Hwang ◽  
Jaehyun Hur ◽  
Jutaek Nam ◽  
...  

A drug delivery vehicle has been prepared by combining gold nanorods and a DNA intercalated drug in a DNA hydrogel, resulting in thermo-chemo combination therapy with photothermal-triggered DNA melting and release of doxorubicin.


Sign in / Sign up

Export Citation Format

Share Document